grant

Cue-induced drug craving monitoring for opioid use disorder with visual evoked potentials

Organization NEUROTYPE INC.Location MINNEAPOLIS, UNITED STATESPosted 30 Sept 2023Deadline 30 Apr 2029
NIHUS FederalResearch GrantFY2026AffectAffectiveAgreementAmbulatory CareAppetiteBenchmarkingBest Practice AnalysisBiological MarkersBrainBrain Nervous SystemClinicClinicalClinical TrialsClinical Trials DesignClinical assessmentsComputer softwareCuesDataData CollectionDesire for foodDevicesDiagnosticDrug PrescribingDrug PrescriptionsDrug ScreeningDrug usageDrugsEEGEffectivenessElectroencephalogramElectroencephalographyEmotionalEncephalonEvent-Related PotentialsFeedbackFoodFood and Drug AdministrationFundingGoalsHospitalsI-CorpsImageIndividualInnovation CorpsLaboratoriesLettersLinkMarketingMeasuresMedicationMethodsMonitorNational Institutes of HealthOpiatesOpioidOut-patientsOutcomeOutpatient CareOutpatientsPatient Self-ReportPatientsPerformancePersonsPharmaceutical PreparationsPhasePopulationPrimary CareProviderPsychotherapyRelapseResearchRiskSBIRSafetySelf-ReportSmall Business Innovation ResearchSmall Business Innovation Research GrantSoftwareStatistical Data AnalysesStatistical Data AnalysisStatistical Data InterpretationStimulusStreamSystemTabletsTechnologyTestingTherapeuticTimeToyTrainingUSFDAUnited StatesUnited States Food and Drug AdministrationUnited States National Institutes of HealthUrineValidationVisual Evoked PotentialsVisual Evoked ResponseVisual evoked cortical potentialWorkbench performance testingbench side testingbench testingbenchmarkbenchtop testingbio-markersbiologic markerbiomarkercognitive reappraisalcognitive regulationcravingdrug cravingdrug relapsedrug usedrug/agentevent related potentialimagingimprovedmedication prescriptionmeetingmeetingsnon-drugnondrugopiate consumptionopiate drug useopiate intakeopiate useopiate use disorderopioid consumptionopioid drug useopioid intakeopioid useopioid use disorderoutpatient treatmentoverdose deathoverdose fatalitiespatient stratificationpillpoint of careportabilitypredict clinical outcomeprescribed medicationprevent relapseprogramsprospectivepsychostimulant use disorderrelapse preventionresponsestatistical analysisstimulant use disorderstratified patienttargeted drug therapytargeted drug treatmentstargeted therapeutictargeted therapeutic agentstargeted therapytargeted treatmenttoolusabilityvalidations
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Description preview

Project Summary / Abstract
More than 2 million people in the United States have an Opioid Use Disorder (OUD). Overall, at least half of

the treatment-seeking population relapse, contributing to over 75,000 overdose deaths annually. The purpose

of this SBIR Fast-Track application is to create a regulated device to objectively monitor Cue-Induced…

🔒

Full details available on the Agency plan

Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.

Start 7-day free trial — $29.99/mo →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →
Cue-induced drug craving monitoring for opioid use disorder with visual evoked potentials — NEUROTYPE INC. | UNITED STAT | Dev Procure